Juno Therapeutics
- Biological Products, Except Diagnostic Substances
- Seattle, Washington
Compensation history
Top executives at Juno Therapeutics received an average of $4M per person in annual compensation from 2013 to 2016.
Average pay of disclosed executives at Juno Therapeutics
By year
- 2016
HB$4MHans E. BishopPresident, Chief Executive Officer and DirectorSH$3MSteven D. HarrChief Financial Officer and Head of Corporate DevelopmentHL$2MHyam LevitskyExecutive Vice President, Research and Chief Scientific OfficerRA$2MRobert AzelbyExecutive Vice President, Chief Commercial OfficerBC$2MBernard J. CassidyGeneral Counsel and Secretary- 2015
HL$14MHyam LevitskyExecutive Vice President, Research and Chief Scientific OfficerRA$10MRobert AzelbyExecutive Vice President, Chief Commercial OfficerHB$5MHans E. BishopPresident, Chief Executive Officer and DirectorSH$3MSteven D. HarrChief Financial Officer and Head of Corporate DevelopmentMF$2MMark W. FrohlichExecutive Vice President, Portfolio Strategy
Executives
We found six executives who work or worked at Juno Therapeutics.
Hans Bishop
Juno Therapeutics
Chief Executive Officer
Robert Azelby
Juno Therapeutics
Executive Vice President, Chief Commercial Officer
Bernard Cassidy
Juno Therapeutics
General Counsel
Steven Harr
Juno Therapeutics
Chief Financial Officer
Hyam Levitsky
Juno Therapeutics
Chief Scientific Officer
Mark Frohlich
Juno Therapeutics
Executive Vice President, Portfolio Strategy
About Juno Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address400 Dexter Avenue North, Suite 1200, Seattle, Washington 98109
- Phone2065821600
- Fiscal year endDecember 31
Source: SEC filings on April 21, 2017 and April 20, 2016.